Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure
Appointed director
Inv. presentation

Celldex Therapeutics, Inc. (CLDX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/06/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/10/2022 SC 13G VIKING GLOBAL INVESTORS LP reports a 5.1% stake in Celldex Therapeutics, Inc.
02/10/2022 SC 13G STATE STREET CORP reports a 5.1% stake in INITIAL FILING CELLDEX THERAPEUTICS INC
02/09/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/04/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/12/2021 SC 13G FMR LLC reports a 12.1% stake in CELLDEX THERAPEUTICS INC
02/25/2021 SC 13G Cowen Financial Products LLC reports a 5.1% stake in Celldex Therapeutics Inc.
02/16/2021 SC 13G Redmile Group, LLC reports a 6.9% stake in Celldex therapeutics, Inc.
10/22/2020 SC 13G Logos Global Management LP reports a 4.3% stake in Celldex Therapeutics, Inc.
07/24/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/26/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/19/2020 SC 13G RTW INVESTMENTS, LLC reports a 10% stake in Celldex Therapeutics, Inc.
06/18/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/12/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
12/09/2016 SC 13G KLP Enterprises, LLC reports a 5.7% stake in Celldex Therapeutics, Inc.
04/08/2016 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
09/10/2013 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
04/22/2013 SC 13G SAC Capital Advisors LP reports a 5.4% stake in CELLDEX THERAPEUTICS, INC.
02/11/2013 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
05/26/2011 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
02/03/2011 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
05/27/2009 SC 13G APAX PARTNERS EUROPE MANAGERS LTD has filed a Schedule 13D for CELLDEX THERAPEUTICS, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy